Abstract
Secretion of inflammatory cytokines is the initial step of the immune response to viral infections. This innate immune response is mediated by the expression of a variety of cytokines, exemplified by tumor necrosis factor-α (TNF-α). The presence of dsRNA during viral infections is a key step in activation of several signaling pathways, including protein kinase R (PKR), toll-like receptor 3 (TLR3), mitogen-activated protein kinase(MAPK), activator protein-1 (AP-1), interferon regulatory factors (IRFs), and NF-κB pathways, which are all relevant in the expression of inflammatory cytokines. We previously reported that PKR and p38 MAPK were required for dsRNA and viral induction of inflammatory cytokines in epithelial cells. Here, we report that activation of c-Jun N-terminal kinase (JNK) during dsRNA treatment or respiratory syncytial viral (RSV) infection negatively regulates the induction of TNF-α in human epithelial cells. Inhibition of JNK by a pharmacologic inhibitor showed that expression of TNF-α increased following both dsRNA treatment and infection with RSV. Importantly, transfection of epithelial cells with a dominant-negative mutant of JNK significantly increased dsRNA induction of TNF-α. The mechanism by which JNK inhibition increases TNF-α induction appears to be through p38 MAPK activation. Our data show that JNK is a negative regulator of dsRNA and RSV induction of TNF-α expression and, thus, may act as a counterbalance to proinflammatory signals generated during viral infections.
Get full access to this article
View all access options for this article.
